Aggressive NK-cell leukemia
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Aggressive NK-cell leukemia Classification and external resources | |
| ICD-O: | 9948/3 |
|---|---|
| eMedicine | ent/776 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Synonyms and related key words: Aggressive Natural Killer cell leukemia
Overview
Aggressive NK-cell leukemia is a disease with an aggressive, systemic proliferation of natural killer cells (NK cells) and a rapidly declining clinical course.[1][1][1]
It is also called aggressive NK-cell lymphoma, or large granular lymphocyte leukemia, NK-cell type[1]
Synonyms
Aggressive NK-cell leukemia/lymphoma, large granular lymphocyte leukemia, NK-cell type[1]
ICD-O code
9948/3[1]
Definition
Aggressive NK-cell leukemia is a disease with an aggressive, systemic proliferation of natural killer cells (NK cells) and a rapidly declining clinical course.[1][1][1]
Epidemiology
This rare form a leukemia is more common among Asians in comparison to other ethnic groups. It is typically diagnosed in adolescents and young adults, with a slight predominance in males.[1][1][1][1][1][1][1]
Clinical features
Etiology
This disease has a strong association with the Epstein-Barr virus (EBV)[1], but the true pathogenesis of this disease has yet to be described. The cell of origin is believed to be an NK cell.[1] Blastoid NK cell lymphoma appears to be a different entity and shows no association with EBV.[1]
Presentation
Patients usually present with constitutional symptoms (malaise, weight loss, fatigue), and hepatosplenomegaly is commonly found on physical exam. Lymphadenopathy is also found to a lesser extent. Due to the aggressive nature of the disease, patients may initially present at a more advanced stage, with coagulopathies, hemophagocytic syndrome, and multi-organ failure.[1][1][1][1][1]
Laboratory findings
Leukemic cells are invariably present in samples of peripheral blood to a variable extent. Pancytopenia (anemia, neutropenia, thrombocytopenia) is commonly seen as well.[1]
Sites of involvement
This disease is typically found and diagnosed in peripheral blood, and while it can involve any organ, it is usually found in the spleen, liver, and bone marrow.[1]
Morphology
Peripheral blood
The leukemic cells have a diameter mildly greater than a large granular lymphocyte (LGL) and have azurophilic granules and nucleoli of varying prominence. Nuclei may be irregular and hyperchromatic.[1]
Bone marrow
Bone marrow involvement runs the spectrum between an inconspicuous infiltrate to extensive marrow replacement by leukemic cells. Reactive histiocytes displaying hemophagocytosis can been seen interspersed in the neoplastic infiltrate.[1]
Other organs
Leukemic involvement of organs is typically destructive on tissue sections with necrosis and possibly angioinvasion, and the monotonous infiltrate may be diffuse or patchy.[1]
Molecular findings
Immunophenotype
The immunophenotype of this disease is the same as extranodal NK/T-cell lymphoma, nasal type and is shown in the table below. CD11b and CD16 show variable expression.[1][1]
| Status | Antigens |
| Positive | CD2, CD3ε, CD56, perforin, granzyme B, TIA-1 |
| Negative | CD57 |
Genetic findings
Due to the myeloid lineage, clonal rearrangements of lymphoid (T cell receptor; B cell receptor) genes are not seen.[1] The genome of the Epstein Barr virus (EBV) is detected in many cases[1], along with a variety of chromosomal abnormalities.[1]
Current articles
References
WikiDoc Research Resources for Aggressive NK-cell leukemia (Click show to right to view) | |
|---|---|
| Articles on Aggressive NK-cell leukemia | Most recent articles on Aggressive NK-cell leukemia • Most cited articles on Aggressive NK-cell leukemia • Review articles on Aggressive NK-cell leukemia • Articles on Aggressive NK-cell leukemia in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Aggressive NK-cell leukemia | Powerpoint slides on Aggressive NK-cell leukemia • Images of Aggressive NK-cell leukemia • Photos of Aggressive NK-cell leukemia • Podcasts & MP3s on Aggressive NK-cell leukemia • Videos on Aggressive NK-cell leukemia |
| Evidence Based Medicine Regarding Aggressive NK-cell leukemia | Cochrane Collaboration on Aggressive NK-cell leukemia • Bandolier on Aggressive NK-cell leukemia • TRIP on Aggressive NK-cell leukemia |
| Cost Effectiveness of Aggressive NK-cell leukemia | Cost Effectiveness of Aggressive NK-cell leukemia |
| Clinical Trials Involving Aggressive NK-cell leukemia | Ongoing Trials on Aggressive NK-cell leukemia at Clinical Trials.gov • Trial results on Aggressive NK-cell leukemia • Clinical Trials on Aggressive NK-cell leukemia at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Aggressive NK-cell leukemia | US National Guidelines Clearinghouse on Aggressive NK-cell leukemia • NICE Guidance on Aggressive NK-cell leukemia • NHS PRODIGY Guidance • FDA on Aggressive NK-cell leukemia • CDC on Aggressive NK-cell leukemia |
| Textbook Information on Aggressive NK-cell leukemia | Books and Textbook Information on Aggressive NK-cell leukemia |
| Pharmacology Resources on Aggressive NK-cell leukemia | Dosing of Aggressive NK-cell leukemia • Drug interactions with Aggressive NK-cell leukemia • Side effects of Aggressive NK-cell leukemia • Allergic reactions to Aggressive NK-cell leukemia • Overdose information on Aggressive NK-cell leukemia • Carcinogenicity information on Aggressive NK-cell leukemia • Aggressive NK-cell leukemia in pregnancy • Pharmacokinetics of Aggressive NK-cell leukemia • |
| Genetics, Pharmacogenomics, and Proteinomics of Aggressive NK-cell leukemia | Genetics of Aggressive NK-cell leukemia • Pharmacogenomics of Aggressive NK-cell leukemia • Proteomics of Aggressive NK-cell leukemia |
| Newstories on Aggressive NK-cell leukemia | Aggressive NK-cell leukemia in the news • Be alerted to news on Aggressive NK-cell leukemia • News trends on Aggressive NK-cell leukemia |
| Commentary on Aggressive NK-cell leukemia | Blogs on Aggressive NK-cell leukemia |
| Patient Resources on Aggressive NK-cell leukemia | Patient resources on Aggressive NK-cell leukemia • Discussion groups on Aggressive NK-cell leukemia • Patient Handouts on Aggressive NK-cell leukemia • Directions to Hospitals Treating Aggressive NK-cell leukemia • Risk calculators and risk factors for Aggressive NK-cell leukemia |
| Healthcare Provider Resources on Aggressive NK-cell leukemia | Symptoms of Aggressive NK-cell leukemia • Causes & Risk Factors for Aggressive NK-cell leukemia • Diagnostic studies for Aggressive NK-cell leukemia • Treatment of Aggressive NK-cell leukemia |
| Continuing Medical Education (CME) Programs on Aggressive NK-cell leukemia | CME Programs on Aggressive NK-cell leukemia |
| International Resources on Aggressive NK-cell leukemia | Aggressive NK-cell leukemia en Espanol • Aggressive NK-cell leukemia en Francais |
| Business Resources on Aggressive NK-cell leukemia | Aggressive NK-cell leukemia in the Marketplace • Patents on Aggressive NK-cell leukemia |
| Informatics Resources on Aggressive NK-cell leukemia | List of terms related to Aggressive NK-cell leukemia |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
